Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04760639 · ClinicalTrials.gov registry record
COVID Breath Test - Ancon
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 100
- Enrollment target
NCT04760639: Completed study, sponsored by Medical University of South Carolina.
NCT04760639 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04760639 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.
Primary Outcome
The samples from the participants will be analyzed to identify the different signals given from Covid-19 positive patients and Covid-19 negative patients
Interventions
- DIAGNOSTIC_TEST Breath test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-12-16 |
| Est. Completion | 2022-09-20 |
What the finished NCT04760639 record still lists
NCT04760639 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Breath test is the first listed.
NCT04760639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04760639 about?
NCT04760639 is a clinical study titled "COVID Breath Test - Ancon". This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by...
What is the current status of trial NCT04760639?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-12-16. Estimated completion is 2022-09-20.
What interventions are being tested in trial NCT04760639?
The interventions under investigation include: Breath test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04760639?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI